申请人:Bristol-Myers Squibb Company
公开号:US06011059A1
公开(公告)日:2000-01-04
Acyl guanidines are provided which are sodium/proton exchange (NHE) inhibitors which have the structure ##STR1## wherein n is 1 to 5; X is N or C--R.sup.5 wherein R.sup.5 is H, halo, alkenyl, alkynyl, alkoxy, alkyl, aryl or heteroaryl; and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined herein, and where X is N, R.sup.1 is preferably aryl or heteroaryl, and are useful as antianginal and cardioprotective agents. In addition, a method is provided for preventing or treating angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia employing the above acyl guanidines.
提供了一种酰基胍,它们是钠/质子交换(NHE)抑制剂,具有以下结构:##STR1## 其中n为1至5;X为N或C--R.sup.5,其中R.sup.5为H,卤素,烯基,炔基,烷氧基,烷基,芳基或杂芳基;而R.sup.1、R.sup.2、R.sup.3和R.sup.4如本文所定义,当X为N时,R.sup.1优选为芳基或杂芳基,可用作抗心绞痛和心脏保护剂。此外,提供了一种使用上述酰基胍预防或治疗心绞痛、心脏功能障碍、心肌坏死和心律失常的方法。